Heart Fatty Acid-Binding Protein (h-FABP) Rapid Detection Kit

Heart Fatty Acid-Binding Protein (h-FABP) Rapid Test is a rapid visual immunoassay for the qualitative presumptive detection of cardiac Heart fatty acid-binding protein (h-FABP) in human whole blood, serum, or plasma specimens. This kit is intended to be used as a screening method to aid in the diagnosis of myocardial infarction (MI).


Heart-type fatty acid binding protein (h-FABP) is known as mammary-derived growth inhibitor is a protein that in humans is encoded by the FABP3 gene. Heart-type Fatty Acid-Binding Protein (H-FABP) is a small cytoplasmic protein (15 kDa) released from cardiac myocytes following an ischemic episode. Like the nine other distinct FABPs that have been identified, H-FABP is involved in active fatty acid metabolism where it transports fatty acids from the cell membrane to mitochondria for oxidation. h-FABP is a sensitive biomarker for myocardial infarction and can be detected in the blood within one to three hours after the onset acute chest pain. The diagnostic potential of the biomarker H-FABP for heart injury was discovered in 1988 by Professor Jan Glatz (Maastricht, Netherlands) h-FABP is 20 times more specific to cardiac muscle than myoglobin, it is found at 10-fold lower levels in skeletal muscle than heart muscle and the amounts in the kidney, liver and small intestine are even lower again.



Ordering Information


1. Phelan CM, Larsson C, Baird S, Futreal PA, Ruttledge MH, Morgan K, Tonin P, Hung H, Korneluk RG, Pollak MN, Narod SA (Dec 1996). "The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumors". Genomics 34 (1): 63–8.

2. Kleine AH, Glatz JF, Van Nieuwenhoven FA, Van der Vusse GJ (October 1992). "Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man". Mol. Cell. Biochem. 116 (1–2): 155–62.

3. Tanaka T, Hirota Y, Sohmiya K, Nishimura S, Kawamura K (April 1991). "Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction". Clin. Biochem. 24 (2): 195–201.

4. Watanabe K, Wakabayashi H, Veerkamp JH, Ono T, Suzuki T (May 1993). "Immunohistochemical distribution of heart-type fatty acid-binding protein immunoreactivity in normal human tissues and in acute myocardial infarct". J. Pathol. 170 (1): 59–65.

5. Glatz JF, van Bilsen M, Paulussen RJ, Veerkamp JH, van der Vusse GJ, Reneman RS (July 1988). "Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox". Biochim. Biophys. Acta 961 (1): 148–52.

6. Ghani F, Wu AH, Graff L, Petry C, Armstrong G, Prigent F, Brown M (May 2000). "Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction". Clin. Chem. 46 (5): 718–9.


About Healgen



Contact Us

Privacy Policy

2020 © Healgen Scientific, LLC. All Rights Reserved. 

Follow Us

  • LinkedIn - White Circle
  • Facebook - White Circle
  • Twitter